157 related articles for article (PubMed ID: 12635559)
1. Clinical aspects of substance abuse in persons with schizophrenia.
Negrete JC
Can J Psychiatry; 2003 Feb; 48(1):14-21. PubMed ID: 12635559
[TBL] [Abstract][Full Text] [Related]
2. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
3. Long-term Administration of Antipsychotic Drugs in Schizophrenia and Influence of Substance and Drug Abuse on the Disease Outcome.
Werner FM; Covenas R
Curr Drug Abuse Rev; 2017; 10(1):19-24. PubMed ID: 29065847
[TBL] [Abstract][Full Text] [Related]
4. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations.
Ziedonis DM; Smelson D; Rosenthal RN; Batki SL; Green AI; Henry RJ; Montoya I; Parks J; Weiss RD
J Psychiatr Pract; 2005 Sep; 11(5):315-39. PubMed ID: 16184072
[TBL] [Abstract][Full Text] [Related]
5. Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review.
De Witte NA; Crunelle CL; Sabbe B; Moggi F; Dom G
Eur Addict Res; 2014; 20(3):105-14. PubMed ID: 24192558
[TBL] [Abstract][Full Text] [Related]
6. [Dual diagnosis psychosis and substance use disorders: theoretical foundations and treatment].
Gouzoulis-Mayfrank E
Z Kinder Jugendpsychiatr Psychother; 2008 Jul; 36(4):245-53. PubMed ID: 18654956
[TBL] [Abstract][Full Text] [Related]
7. [Addiction and schizophrenia. Nosological, clinical and therapeutic questions. 2. Substance dependence and schizophrenia].
Soyka M
Fortschr Neurol Psychiatr; 1994 Jun; 62(6):186-96. PubMed ID: 8050773
[TBL] [Abstract][Full Text] [Related]
8. Pharmacotherapy of schizophrenia patients with comorbid substance abuse.
Wilkins JN
Schizophr Bull; 1997; 23(2):215-28. PubMed ID: 9165632
[TBL] [Abstract][Full Text] [Related]
9. Clozapine treatment in patients with prior substance abuse.
Kelly DL; Gale EA; Conley RR
Can J Psychiatry; 2003 Mar; 48(2):111-4. PubMed ID: 12655909
[TBL] [Abstract][Full Text] [Related]
10. Management of substance use disorder in schizophrenia patients: current guidelines.
Drake RE
CNS Spectr; 2007 Oct; 12(10 Suppl 17):27-32. PubMed ID: 17934387
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological treatment of schizophrenia and co-occurring substance use disorders.
Smelson DA; Dixon L; Craig T; Remolina S; Batki SL; Niv N; Owen R
CNS Drugs; 2008; 22(11):903-16. PubMed ID: 18840032
[TBL] [Abstract][Full Text] [Related]
12. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
13. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
14. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
15. Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial.
Potvin S; Stip E; Lipp O; Elie R; Mancini-Marië A; Demers MF; Roy MA; Bouchard RH; Gendron A
Curr Med Res Opin; 2006 Jul; 22(7):1277-85. PubMed ID: 16834826
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
17. Psychosocial treatments for people with co-occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence.
Horsfall J; Cleary M; Hunt GE; Walter G
Harv Rev Psychiatry; 2009; 17(1):24-34. PubMed ID: 19205964
[TBL] [Abstract][Full Text] [Related]
18. Substance abuse and schizophrenia: editors' introduction.
Kosten TR; Ziedonis DM
Schizophr Bull; 1997; 23(2):181-6. PubMed ID: 9165628
[TBL] [Abstract][Full Text] [Related]
19. Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders.
Crockford D; Addington D
Can J Psychiatry; 2017 Sep; 62(9):624-634. PubMed ID: 28886671
[TBL] [Abstract][Full Text] [Related]
20. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
